Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 229,650 | 174,346 | 72,431 | 67,414 | 62,932 |
| Cost of Goods | 24,723 | 20,240 | 22,393 | 18,408 | 15,476 |
| Gross Profit | 204,927 | 154,106 | 50,038 | 49,006 | 47,456 |
| Operating Expenses | 160,334 | 108,929 | 49,927 | 45,719 | 45,875 |
| Operating Income | 45,316 | 45,417 | 504 | 3,695 | 2,057 |
| Interest Expense | 1,070 | 1,569 | 1,729 | 1,920 | 3,407 |
| Other Income | 2,337 | 1,196 | 831 | 981 | 3,996 |
| Pre-tax Income | 46,583 | 45,044 | -394 | 2,756 | 2,646 |
| Income Tax | 10,472 | 8,339 | 2,664 | 2,985 | 1,458 |
| Net Income Continuous | 36,111 | 36,705 | -3,058 | -229 | 1,188 |
| Net Income Discontinuous | N/A | N/A | 2,338 | -728 | -1,524 |
| Minority Interests | 14,329 | 10,898 | -124 | 459 | 515 |
| Net Income | $21,782 | $25,807 | $-596 | $-1,416 | $-851 |
| EPS Basic Total Ops | 0.34 | 0.45 | -0.01 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | 0.56 | 0.64 | -0.05 | 0.00 | 0.02 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.04 | -0.01 | -0.03 |
| EPS Diluted Total Ops | 0.34 | 0.45 | -0.01 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | 0.56 | 0.64 | -0.05 | 0.00 | 0.02 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.04 | -0.01 | -0.03 |
| EPS Diluted Before Non-Recurring Items | 0.33 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $50,203 | $50,055 | $5,567 | $9,953 | $9,886 |